More on QNRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.8 Score)

Upcoming Events

- Earnings (11/7/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Quoin Pharmaceuticals Ltd (NQ:QNRX)
Delayed: 4.02 +0.01 (0.25%)
Prev. Close $4.01  
Open$4.08 
52 Wk High$ 
52 Wk Low$ 
Day High$4.08 
Day Low$4.02 
P/E N/A  
EPS$ 
Volume2,541 

Friends, Peers and Foes (?): 2EB0 (more...)

Oct 20, 2026 06:35 AM Form 8-K Quoin Pharmaceuticals For: Oct 20
Oct 20, 2026 06:33 AM Quoin Pharmaceuticals publishes peer-reviewed paper on QRX003 for rare skin disease
Oct 20, 2026 06:30 AM Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
Oct 19, 2026 05:31 AM Canaccord Starts Quoin Pharmaceuticals (QNRX) at Buy
Oct 14, 2026 06:35 AM Form 8-K Quoin Pharmaceuticals For: Oct 14
Oct 14, 2026 06:30 AM EMA grants orphan drug status to Quoin's QRX003 for skin disorder
Oct 14, 2026 06:30 AM Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Oct 12, 2026 06:05 AM BTIG Starts Quoin Pharmaceuticals (QNRX) at Buy
Oct 7, 2026 05:14 PM Form SCHEDULE 13G/A Quoin Pharmaceuticals Filed by: Ikarian Capital, LLC
Oct 6, 2026 06:32 AM Quoin Pharmaceuticals' QRX003 paper accepted in dermatology journal
View All Articles

Entities mentioned with QNRX

View All Entities